Olga Ostrovetsky1, Neel P Chudgar1
1Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
新辅助化学免疫疗法和EGFR-TKI治疗改善了早期非小细胞肺癌的结果. 外科医生必须了解治疗诱导的组织变化,以便在这个不断变化的治疗环境中进行最佳的手术管理.
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论:
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014